UNSPSC 51293610: Tiflucarbine

This classification denotes a serotonin agonist and antidepressant agent with the molecular formula C16H17FN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M2108NUY0C, chemically known as 9-ethyl-4-fluoro-7,8,9,10-tetrahydro-1-methyl-6h-pyrido(4,3-b)thieno(3,2-e)indole but generally known as tiflucarbine, which bears US NIH Compound Identifier 65677. European Medicines Agency schedules Tiflucarbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11043MIG.

UNSPSC 51293610 Tiflucarbine is a Commodity code with minimal recent state and local activity. The single recent opportunity on record involves procurement of naloxone and drug deactivation systems — products with distinct end uses in emergency medical response and controlled-substance disposal — rather than tiflucarbine, an anti-infective pharmaceutical. The mismatch suggests the code may be applied inconsistently in state and local procurement systems, or that tiflucarbine itself sees little direct procurement through open state and local solicitations.

Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through a competitive bidding process with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The county required electronic bid submission, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and accepted a two-year initial term with one-year renewal option. The procurement noted potential FEMA funding and associated federal compliance requirements. No explicit set-aside designations appeared in the notice. Beyond this single opportunity, the code reports no recent state and local contracting activity to assess geographic spread or issuing-body patterns.